Alnylam Pharmaceuticals I... (ALNY)
267.06
11.30 (4.42%)
At close: Apr 02, 2025, 3:59 PM
261.99
-1.90%
After-hours: Apr 02, 2025, 06:07 PM EDT
Alnylam Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 |
| Cash & Equivalents | 127.13M | 812.69M | 866.39M | 819.98M | 496.58M | 547.18M | 420.15M | 645.36M | 193.62M | 1.28B | 881.93M | 53.17M | 51.41M | 70.23M | 74.6M | 137.47M | 191.79M | 105.16M | 127.95M | 15.76M | 20.27M | 23.19M | 15.48M |
| Short-Term Investments | 1.73B | 1.63B | 1.33B | 1.62B | 1.38B | 988.98M | 664.01M | 1.05B | 433.18M | 51.42M | 94.58M | 192.7M | 71.41M | 76.17M | 158.53M | 143.93M | 238.6M | 350.44M | 89.31M | 64.25M | 25.77M | n/a | n/a |
| Long-Term Investments | n/a | n/a | -2.56B | 40.89M | 40.73M | 14.82M | 44.83M | 30M | 9M | 251.84M | 279.82M | 45.45M | 38.75M | 564K | 3.62M | 6.43M | 1.58M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 133.9M | -576.39M | 115.48M | n/a | 500M | n/a | n/a | n/a | 150M | -251.84M | 279.82M | n/a | n/a | 114.97M | 120.39M | 151.98M | 85.47M | 15.45M | 3.12M | 2.86M | 2.83M | 2.36M | 66K |
| Receivables | 405.31M | 327.79M | 237.96M | 198.57M | 102.41M | 43.01M | 18.76M | 34M | 23.33M | 8.3M | 39.94M | 4.25M | 104K | 1.47M | 14.12M | 6.04M | n/a | 5.03M | 3.83M | 755K | 1.17M | n/a | n/a |
| Inventory | 78.51M | 89.15M | 128.96M | 122.7M | 92.3M | 56.35M | 24.07M | 1.00 | 1.00 | 1.00 | n/a | 1.00 | n/a | -142.24M | -226.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 116.96M | 126.38M | 132.92M | n/a | 562.77M | n/a | n/a | n/a | n/a | n/a | 9.74M | 3.91M | n/a | n/a | n/a | 1.94M | 4.67M | n/a | n/a | n/a | n/a | 373K | 19K |
| Total Current Assets | 3.3B | 2.98B | 2.69B | 2.87B | 2.16B | 1.73B | 1.21B | 1.78B | 989.24M | 1.36B | 1.03B | 358.63M | 228.97M | 266.44M | 370.91M | 293.53M | 442.25M | 463.56M | 222.78M | 82.41M | 48.18M | 24.19M | 15.52M |
| Property-Plant & Equipment | 693.93M | 725.79M | 738.63M | 733.63M | 706.51M | 646.38M | 320.66M | 181.9M | 114.57M | 27.81M | 21.74M | 16.45M | 19.8M | 14.64M | 18.29M | 18.32M | 19.19M | 13.81M | 12.17M | 10.58M | 11.69M | 4.76M | 526K |
| Goodwill & Intangibles | n/a | 697.78M | 264.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -559.64M | n/a | n/a | 275K | 448K | 622K | 795K | 968K | 1.93M | 2.49M | 3.4M | 3.88M | n/a |
| Total Long-Term Assets | 944.7M | 847.18M | 854.11M | 774.52M | 1.25B | 661.2M | 365.48M | 211.9M | 273.57M | 27.81M | 53.41M | 61.9M | 58.55M | 15.48M | 22.35M | 187.85M | 112.43M | 30.23M | 17.22M | 15.93M | 17.93M | 10.99M | 592K |
| Total Assets | 4.24B | 3.83B | 3.55B | 3.64B | 3.41B | 2.4B | 1.57B | 1.99B | 1.26B | 1.39B | 1.08B | 420.53M | 287.52M | 281.92M | 393.26M | 481.38M | 554.68M | 493.79M | 240.01M | 98.35M | 66.11M | 35.18M | 16.11M |
| Account Payables | 88.42M | 55.52M | 98.09M | 73.43M | 51.97M | 49.88M | 59.71M | 28.36M | 54.47M | 16.79M | 15.11M | 5.9M | 4.42M | 5.8M | 9.31M | 12.49M | 2.59M | 3.83M | 4.08M | 1.98M | 910K | 1.51M | 674K |
| Deferred Revenue | 55.48M | 102.75M | 42.1M | 301.84M | 352.3M | 396.2M | 3.95M | 84.78M | 82.93M | 68.32M | 66.85M | 126.09M | 132.29M | 62.37M | 211.11M | 81.93M | 79.86M | 59.25M | 11.14M | 10.73M | 1M | 333K | n/a |
| Short-Term Debt | n/a | 54.99M | 40.29M | 37.08M | 13.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.79M | 3.22M | 1.88M | 790K | 558K | n/a |
| Other Current Liabilities | 327.42M | 590.84M | 414.77M | 301.59M | 258.48M | 128.9M | 78.99M | 40.37M | 30M | 17.64M | 16.32M | 5.93M | 950K | 484K | n/a | n/a | 1.56M | n/a | n/a | n/a | 3.19M | n/a | n/a |
| Total Current Liabilities | 1.19B | 967.79M | 767.91M | 1.19B | 1.13B | 956.44M | 242.84M | 198.3M | 192.59M | 121.8M | 143.33M | 150.18M | 153.47M | 18.14M | 231.54M | 110.73M | 99.45M | 82.09M | 22.93M | 18.48M | 6.58M | 3.84M | 2.67M |
| Long-Term Debt | n/a | 2.34B | 2.27B | 1.83B | 191.28M | 276.13M | 30M | 30M | 150M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.96M | 5.92M | 5.52M | 6.41M | 1.3M | n/a |
| Other Long-Term Liabilities | 2.99B | 308.44M | 212.58M | 98.96M | 1.1B | -266.81M | 62.88M | 10.97M | 11.5M | 6.73M | 5.01M | 2.92M | 4.25M | 716K | 3.01M | 2.8M | 2.98M | 5.5M | 3.2M | n/a | n/a | 56.74M | 18.08M |
| Total Long-Term Liabilities | 2.99B | 3.08B | 2.94B | 1.86B | 1.26B | 603.85M | 30M | 30M | 150M | 59.7M | 47.99M | 96.32M | 105.12M | 145.78M | 3.5M | 192.69M | 253.1M | 212.53M | 15.91M | 18.09M | 13.39M | 58.05M | 18.08M |
| Total Liabilities | 4.17B | 4.05B | 3.7B | 3.06B | 2.39B | 956.44M | 272.84M | 228.3M | 342.59M | 121.8M | 143.33M | 150.18M | 153.47M | 163.92M | 235.03M | 303.42M | 352.55M | 294.62M | 38.83M | 36.57M | 19.96M | 61.89M | 20.76M |
| Total Debt | 1.3B | 2.68B | 1.32B | 997.59M | 521.19M | 303.82M | 30M | 30M | 150M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.76M | 9.14M | 7.39M | 7.2M | 1.86M | n/a |
| Common Stock | 1.29M | 1.26M | 1.24M | 1.2M | 1.16M | 1.12M | 1.01M | 997K | 859K | 851K | 772K | 637K | 525K | 427K | 423K | 418K | 414K | 408K | 371K | 267K | 208K | n/a | n/a |
| Retained Earnings | n/a | -7.01B | -6.57B | -5.44B | -4.59B | -3.73B | -2.84B | -2.15B | -1.66B | -1.25B | -956.63M | -596.24M | -507.01M | -401M | -343.35M | -299.83M | -252.24M | -225.99M | -140.53M | -105.92M | -63.01M | -29.52M | -4.49M |
| Comprehensive Income | n/a | -23.38M | -44.65M | -33.26M | -43.62M | -36.52M | -33.21M | -34.43M | -33.44M | 4.37M | 48.76M | 19.72M | 15.66M | -165K | 714K | 716K | 1.19M | 300K | 551K | -2.6M | -3.28M | -4.61M | -161K |
| Shareholders Equity | 67.09M | -220.64M | -158.22M | 588.2M | 1.02B | 1.44B | 1.3B | 1.77B | 920.22M | 1.26B | 936.27M | 270.35M | 134.05M | 118M | 158.23M | 177.97M | 202.13M | 199.17M | 201.17M | 61.78M | 46.14M | -26.71M | -4.65M |
| Total Investments | 1.73B | 1.63B | 1.33B | 1.62B | 1.38B | 1B | 664.01M | 1.06B | 757.98M | 1.15B | 901.33M | 342.75M | 213.57M | 191.15M | 278.92M | 304.28M | 322.5M | 350.44M | 89.31M | 64.25M | 25.77M | n/a | n/a |